PRDM1 and rheumatoid arthritis: Blimp-1 may be a pivotal target for the modulation of the balance between pro- and anti-inflammatory responses, thereby dampening the chronic inflammation that characterizes diseases such as rheumatoid arthritis, inflammatory bowel disease, and asthma.